1. Home
  2. RYI vs HUMA Comparison

RYI vs HUMA Comparison

Compare RYI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryerson Holding Corporation

RYI

Ryerson Holding Corporation

HOLD

Current Price

$26.27

Market Cap

843.2M

Sector

Industrials

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.07

Market Cap

236.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYI
HUMA
Founded
1842
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
843.2M
236.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RYI
HUMA
Price
$26.27
$1.07
Analyst Decision
Hold
Strong Buy
Analyst Count
1
8
Target Price
$25.00
$10.13
AVG Volume (30 Days)
359.7K
4.3M
Earning Date
10-28-2025
11-12-2025
Dividend Yield
2.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,473,900,000.00
$1,571,000.00
Revenue This Year
$0.38
N/A
Revenue Next Year
$4.72
$698.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.18
$1.04
52 Week High
$27.41
$5.66

Technical Indicators

Market Signals
Indicator
RYI
HUMA
Relative Strength Index (RSI) 66.86 36.35
Support Level $23.57 $1.04
Resistance Level $26.72 $1.17
Average True Range (ATR) 0.96 0.08
MACD 0.15 -0.01
Stochastic Oscillator 90.86 10.03

Price Performance

Historical Comparison
RYI
HUMA

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: